Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2022 / N 2

Системная красная волчанка и инфекции
О.А. Георгинова, П.Н. Асташкевич, Т.Н. Краснова

References

1. Zandman-Goddard G, Shoenfeld Y. Infections and SLE. Autoimmunity 2005 Nov;38(7):473-85.
2. Bouza E, Moya JGL, Muñoz P. Infections in systemic lupus erythematosus and rheumatoid arthritis. Infectious Diseases Clinics of North America 2001 Jun;15(2):335-61, vii.
3. Doaty S, Agrawal H, Bauer E, Furst DE. Infection and lupus: which causes which? Current Rheumatology Reports 2016 Mar;18(3):13.
4. Pasoto SG, Ribeiro ACM, Bonfa E. Update on infections and vaccinations in systemic lupus erythematosus and Sjögren’s syndrome. Current Opinion in Rheumatology 2014 Sep;26(5):528-37.
5. Esposito S, Bosis S, Semino M, Rigante D. Infections and systemic lupus erythematosus. European Journal of Clinical Microbiology & Infectious Diseases 2014 Sep;33(9):1467-75.
6. Li ZX, Zeng S, Wu HX, Zhou Y. The risk of systemic lupus erythematosus associated with Epstein–Barr virus infection: a systematic review and meta-analysis. Clinical and Experimental Medicine 2019 Feb;19(1):23-36.
7. Valencia Pacheco G, Nakazawa Ueji YE, Rodríguez Dzul EA, Angulo Ramírez AV, López Villanueva RF, Quintal Ortíz IG, Rosado Paredes EP. Serological and molecular analysis of parvovirus B19 infection in Mayan women with systemic lupus erythematosus in Mexico. Colombia Médica (Cali, Colombia) 2017 Sep;48(3):105-12.
8. Pisetsky DS. Role of Epstein–Barr virus infection in SLE: gene-environment interactions at the molecular level. Annals of the Rheumatic Diseases 2018 Sep;77(9):1249-50.
9. Skare TL, Dagostini JS, Zanardi PI, Nisihara RM. Infections and systemic lupus erythematosus. Einstein (São Paulo, Brazil) 2016 Jan;14(1):47-51.
10. Seyyed Mousavi MN, Mehramuz B, Sadeghi J, Alizadeh N, Oskouee MA, Kafil HS. The pathogenesis of Staphylococcus aureus in autoimmune diseases. Microbial Pathogenesis 2017 Oct;111:503-7.
11. Rigante D, Esposito S. Infections and systemic lupus erythematosus: binding or sparring partners? International Journal of Molecular Sciences 2015 Jul;16(8):17331-43.
12. Long H, Wang X, Chen Y, Wang L, Zhao M, Lu Q. Dysregulation of microRNAs in autoimmune diseases: pathogenesis, biomarkers and potential therapeutic targets. Cancer Letters 2018 Aug;428:90-103.
13. Rigante D, Mazzoni MB, Esposito S. The cryptic interplay between systemic lupus erythematosus and infections. Autoimmunity Reviews 2014 Feb;13(2):96-102.
14. Pan Q, Liu Z, Liao S, Ye L, Lu X, Chen X, Li Z, Li X, Xu YZ, Liu H. Current mechanistic insights into the role of infection in systemic lupus erythematosus. Biomedicine & Pharmacotherapy 2019 Sep;117:109122.
15. Evans AS, Rothfield NF, Niederman JC. Raised antibody titres to E.B. virus in systemic lupus erythematosus. The Lancet 1971 Jan;1(7691):167-8.
16. Hanlon P, Avenell A, Aucott L, Vickers MA. Systematic review and meta-analysis of the sero-epidemiological association between Epstein–Barr virus and systemic lupus erythematosus. Arthritis Research & Therapy 2014 Jan;16(1):R3.
17. Georges E, Rihova Z, Cmejla R, Decleire PY, Langen C. Parvovirus B19 induced lupus-like syndrome with nephritis. Acta Clinica Belgica 2016 Dec;71(6):423-5.
18. Page C, François C, Goëb V, Duverlie G. Human parvovirus B19 and autoimmune diseases. Review of the literature and pathophysiological hypotheses. Journal of Clinical Virology 2015 Nov;72:69-74.
19. Hession MT, Shiu-Chung AU, Gottlieb AB. Parvovirus B19-associated systemic lupus erythematosus: clinical mimicry or autoimmune induction? The Journal of Rheumatology 2010 Nov;37(11):2430-2.
20. Speyer I, Breedveld FC, Dijkmans BA. Human parvovirus B19 infection is not followed by inflammatory joint disease during long term follow-up. A retrospective study of 54 patients. Clinical and Experimental Rheumatology 1998 Sep-Oct;16(5):576-8.
21. Tugnet N, Rylance P, Roden D, Trela M, Nelson P. Human endogenous retroviruses (HERVs) and autoimmune rheumatic disease: is there a link? The Open Rheumatology Journal 2013 Mar;7(1):13-21.
22. Pullmann R, Bonilla E, Phillips PE, Middleton FA, Perl A. Haplotypes of the HRES-1 endogenous retrovirus are associated with development and disease manifestations of systemic lupus erythematosus. Arthritis and Rheumatism 2008 Feb;58(2):532-40.
23. Wu Z, Mei X, Zhao D, Sun Y, Song J, Pan W, Shi W. DNA methylation modulates HERV-E expression in CD4+ T cells from systemic lupus erythematosus patients. Journal of Dermatological Science 2015 Feb;77(2):110-6.
24. Yamazaki S, Endo A, Iso T, Abe S, Aoyagi Y, Suzuki M, Fujii T, Haruna H, Ohtsuka Y, Shimizu T. Cytomegalovirus as a potential trigger for systemic lupus erythematosus: a case report. BMC Research Notes 2015 Sep;8:487.
25. Rasmussen N, Draborg A, Nielsen C, Jacobsen S, Houen G. Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients. Scandinavian Journal of Rheumatology 2015;44(2):143-9.
26. Illescas-Montes R, Corona-Castro CC, Melguizo-Rodríguez L, Ruiz C, Costela-Ruiz VJ. Infectious processes and systemic lupus erythematosus. Immunology 2019 Nov;158(3):153-60.
27. Deng GM, Tsokos GC. Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation. The Journal of Immunology (Baltimore, Md.: 1950) 2008 Sep;181(6):4019-26.
28. Nicastro L, Tükel Ç. Bacterial amyloids: the link between bacterial infections and autoimmunity. Trends in Microbiology 2019 Nov;27(11):954.
29. Gallo PM, Rapsinski GJ, Wilson RP, Oppong GO, Sriram U, Goulian M, Buttaro B, Caricchio R, Gallucci S, Tükel Ç. Amyloid-DNA composites of bacterial biofilms stimulate autoimmunity. Immunity 2015 Jun;42(6):1171-84.
30. Spaulding CN, Dodson KW, Chapman MR, Hultgren SJ. Fueling the fire with fibers: bacterial amyloids promote inflammatory disorders. Cell Host & Microbe 2015 Jul;18(1):1-2.
31. Versini M, Jeandel PY, Bashi T, Bizzaro G, Blank M, Shoenfeld Y. Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications. BMC Medicine 2015 Apr;13(1):81.
32. Weinstock JV. Autoimmunity: the worm returns. Nature 2012 Nov;491(7423):183-5.
33. Oldstone MBA, Dixon FJ. Inhibition of antibodies to nuclear antigen and to DNA in New Zealand mice infected with lactate dehydrogenase virus. Science 1972 Feb;175(4023):784-6.
34. Willcocks LC, Carr EJ, Niederer HA, Rayner TF, Williams TN, Yang W, Scott AJ, Urban BC, Peshu N, Vyse TJ, Lau YL, Lyons PA, Smith KGC. A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus. Proceedings of the National Academy of Sciences of the USA 2010 Apr;107(17):7881-5.
35. Badr G, Sayed A, Abdel-Maksoud MA, Mohamed AO, El-Amir A, Abdel-Ghaffar FA, Al-Quraishy S, Mahmoud MH. Infection of female BWF1 lupus mice with malaria parasite attenuates B cell autoreactivity by modulating the CXCL12/CXCR4 axis and its downstream signals PI3K/AKT, NFκB and ERK. PLoS One 2015 Apr;10(4):e0125340.
36. Chen M, Aosai F, Norose K, Mun HS, Ishikura H, Hirose S, Piao LX, Fang H, Yano A. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice. International Immunology 2004 Jul;16(7):937-46.
37. Rodgers DT, McGrath MA, Pineda MA, Al-Riyami L, Rzepecka J, Lumb F, Harnett W, Harnett MM. The parasitic worm product ES-62 targets myeloid differentiation factor 88-dependent effector mechanisms to suppress antinuclear antibody production and proteinuria in MRL/lpr mice. Arthritis & Rheumatology (Hoboken, N.J.) 2015 Apr;67(4):1023-35.
38. Sawalha AH, Schmid WR, Binder SR, Bacino DK, Harley JB. Association between systemic lupus erythematosus and Helicobacter pylori seronegativity. The Journal of Rheumatology 2004 Aug;31(8):1546-50.
39. Zhao J, Qiu M, Li M, Lu C, Gu J. Low prevalence of hepatitis B virus infection in patients with systemic lupus erythematosus in southern China. Rheumatology International 2010 Nov;30(12):1565-70.
40. Wang Z, Wang Y, Zhu R, Tian X, Xu D, Wang Q, Wu C, Zhang S, Zhao J, Zhao Y, Li M, Zeng X. Long-term survival and death causes of systemic lupus erythematosus in China: a systemic review of observational studies. Medicine 2015 May;94(17):e794.
41. Goldblatt F, Chambers S, Rahman A, Isenberg DA. Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus 2009 Jul;18(8):682-9.
42. Singh BK, Singh S. Systemic lupus erythematosus and infections. Reumatismo 2020 Nov;72(3):154-69.
43. Danza A, Ruiz-Irastorza G. Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies. Lupus 2013 Oct;22(12):1286-94.
44. Feldman CH, Hiraki LT, Winkelmayer WC, Marty FM, Franklin JM, Kim SC, Costenbader KH. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis. Arthritis & Rheumatology (Hoboken, N.J.) 2015 Jun;67(6):1577-85.
45. Jung JY, Suh CH. Infection in systemic lupus erythematosus, similarities, and differences with lupus flare. The Korean Journal of Internal Medicine 2017 May;32(3):429-38.
46. Marcos M, Fernández C, Soriano À, Marco F, Martínez JA, Almela M, Cervera R, Mensa J, Espinosa G. Epidemiology and clinical outcomes of bloodstream infections among lupus patients. Lupus 2011 Aug;20(9):965-71.
47. Abramson S, Kramer SB, Radin A, Holzman R. Salmonella bacteremia in systemic lupus erythematosus. Eight-year experience at a municipal hospital. Arthritis and Rheumatism 1985 Jan;28(1):75-9.
48. Gladman DD, Hussain F, Iban D, Urowitz MB. The nature and outcome of infection in systemic lupus erythematosus. Lupus 2002;11(4):234-9.
49. Borba EF, Ribeiro ACM, Martin P, Costa LP, Guedes LKN, Bonfá E. Incidence, risk factors, and outcome of Herpes zoster in systemic lupus erythematosus. Journal of Clinical Rheumatology 2010 Apr;16(3):119-22.
50. Rider JR, Ollier WE, Lock RJ, Brookes ST, Pamphilon DH. Human cytomegalovirus infection and systemic lupus erythematosus. Clinical and Experimental Rheumatology 1997 Jul-Aug;15(4):405-9.
51. Ramos-Casals M, Cuadrado MJ, Alba P, Sanna G, Brito-Zerón P, Bertolaccini L, Babini A, Moreno A, D’Cruz D, Khamashta MA. Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature. Medicine 2008 Nov;87(6):311-8.
52. Nath R, Mant C, Luxton J, Hughes G, Raju KS, Shepherd P, Cason J. High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients. Arthritis and Rheumatism 2007;57(4):619-25.
53. Zonana-Nacach A, Camargo-Coronel A, Yañez P, Sánchez L, Jimenez-Balderas FJ, Fraga A. Infections in outpatients with systemic lupus erythematosus: a prospective study. Lupus 2001;10(7):505-10.
54. Cuchacovich R, Gedalia A. Pathophysiology and clinical spectrum of infections in systemic lupus erythematosus. Rheumatic Disease Clinics of North America 2009 Feb;35(1):75-93.
55. Lin YC, Liang SJ, Liu YH, Hsu WH, Shih CM, Sung FC, Chen W. Tuberculosis as a risk factor for systemic lupus erythematosus: results of a nationwide study in Taiwan. Rheumatology International 2012 Jun;32(6):1669-73.
56. Sayarlioglu M, Inanc M, Kamali S, Cefle A, Karaman O, Gul A, Ocal L, Aral O, Konice M. Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization. Lupus 2004;13(4):274-8.
57. Wang J, Pan HF, Su H, Li XP, Xu JH, Ye DQ. Tuberculosis in systemic lupus erythematosus in Chinese patients. Tropical Doctor 2009 Jul;39(3):165-7.
58. Torres-González P, Romero-Díaz J, Cervera-Hernández ME, Ocampo-Torres M, Chaires-Garza LG, Lastiri-González EA, Atisha-Fregoso Y, Bobadilla-del-Valle M, Ponce-de-León A, Sifuentes-Osornio J. Tuberculosis and systemic lupus erythematosus: a case–control study in Mexico City. Clinical Rheumatology 2018 Aug;37(8):2095-102.
59. Sawalha AH. Patients with lupus are not protected from COVID-19. Annals of Rheumatic Diseases 2021;80(2):e21.
60. Sawalha AH, Zhao M, Coit P, Lu Q. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients. Clinical Immunology (Orlando, Fla.) 2020 Jun;215:108410.
61. Niewold TB. Interferon alpha as a primary pathogenic factor in human lupus. Journal of Interferon & Cytokine Research 2011 Dec;31(12):887-92.
62. Bozzalla Cassione E, Zanframundo G, Biglia A, Codullo V, Montecucco C, Cavagna L. COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine. Annals of the Rheumatic Diseases 2020 Oct;79(10):1382-3.
63. Gendebien Z, von Frenckell C, Ribbens C, André B, Thys M, Gangolf M, Seidel L, Malaise MG, Malaise O. Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments. Annals of the Rheumatic Diseases 2020 Jun;80(6):e94.
64. Mathian A, Mahevas M, Rohmer J, Roumier M, Cohen-Aubart F, Amador-Borrero B, Barrelet A, Chauvet C, Chazal T, Delahousse M, Devaux M, Euvrard R, Fadlallah J, Florens N, Haroche J, Hié M, Juillard L, Lhote R, Maillet T, Richard-Colmant G, Palluy JB, Pha M, Perard L, Remy P, Rivière E, Sène D, Sève P, Morélot-Panzini C, Viallard JF, Virot JS, Benameur N, Zahr N, Yssel H, Godeau B, Amoura Z. Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine. Annals of the Rheumatic Diseases 2020 Jun;79(6):837-9.
65. Xu K, Chen Y, Yuan J, Yi P, Ding C, Wu W, Li Y, Ni Q, Zou R, Li X, Xu M, Zhang Y, Zhao H, Zhang X, Yu L, Su J, Lang G, Liu J, Wu X, Guo Y, Tao J, Shi D, Yu L, Cao Q, Ruan B, Liu L, Wang Z, Xu Y, Liu Y, Sheng J, Li L. Factors associated with prolonged viral RNA shedding in patients with coronavirus disease 2019 (COVID-19). Clinical Infectious Diseases 2020 Jul;71(15):799-806.
66. Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus EF, Rush S, Schmajuk G, Simard J, Strangfeld A, Trupin L, Wysham KD, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Yazdany J, Machado PM, Robinson PC; COVID-19 Global Rheumatology Alliance. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Annals of the Rheumatic Diseases 2020;79(7):859-66.
67. Fernandez-Ruiz R, Masson M, Kim MY, Myers B, Haberman RH, Castillo R, Scher JU, Guttmann A, Carlucci PM, Deonaraine KK, Golpanian M, Robins K, Chang M, Belmont HM, Buyon JP, Blazer AD, Saxena A, Izmirly PM. Leveraging the United States epicenter to provide insights on COVID-19 in patients with systemic lupus erythematosus. Arthritis & Rheumatology (Hoboken, N.J.) 2020;72(12):1971-80.
68. Gartshteyn Y, Askanase AD, Schmidt NM, Bernstein EJ, Khalili L, Drolet R, Broderick RJ, Geraldino-Pardilla L, Kapoor T. COVID-19 and systemic lupus erythematosus: a case series. The Lancet. Rheumatology 2020 Aug;2(8):e452-4.
69. Fung M, Babik JM. COVID-19 in immunocompromised hosts: what we know so far. Clinical Infectious Diseases 2021 Jan;72(2):340-50.
  

[ Содержание выпуска N 2 | Выпуски журнала | Список журналов ]